Insight
Life Sciences Snapshot – Q2 2024 – A Quarterly Report on Financing Trends
21 minute read | June.26.2024
21 minute read | June.26.2024
by Stephen Thau, Albert Vanderlaan and George Pothoulakis
6 minute read | January.30.2024
Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.
by Jedd Bellman and Daniel Bellovin
25 minute read | January.16.2024
As fintech disrupts finance, legal and regulatory questions intensify for industry players.
by Harry Clark, Jeanine P. McGuinness, Elizabeth Zane, Benjamin Hutten, Gregory I. Hume, Maria Sergeyeva and Allison Lofgren Bradham
10 minute read | June.25.2024
by Anna Aryankalayil and Craig Falls
6 minute read | January.23.2024
by Meg Hennessey and Alison Epperson
1 minute read | May.08.2024
by Benjamin Hutten, Jeanine P. McGuinness, Harry Clark and Maria Sergeyeva
7 minute read | January.10.2024
President Biden issued an executive order on December 22, 2023 targeting evasion of U.S. sanctions on Russia. Executive Order 14,114
by Ashley Walter, Hayden Goudy, Avani Panchal and Meghan Conway
8 minute read | June.03.2024
by Franziska Gräfin Grote LL.M. and Siegfried H. Elsing Prof. Dr. LL.M. (Yale)
3 minute read | June.20.2024
by Tim Carroll
1 minute read | June.20.2024
by Shannon Yavorsky, David Curtis and Melissa Klimkiewicz
3 minute read | June.18.2024
by Aravind Swaminathan and Adele Harrison
5 minute read | June.06.2024